Bill Caldwell, Chairman & CEO of Advanced Cell Technology, talks about the FDA clearing a clinical trial using cells derived from human embryonic stem cells, and an eye condition (Dry Age Related Macular Degeneration) which affects 10 million people in the USA for which there is no known therapeutic treatment.
R.I.P William Caldwell IV
gman7111 1 year ago